Austrian Journalists Expose Counterfeit Ozempic Risks Amid Rising Demand
Austrian journalists have uncovered a surge in counterfeit Ozempic, a medication for type 2 diabetes, as demand escalates due to its weight-loss effects. Authorities report hospitalizations linked to fake Ozempic pens containing insulin instead of semaglutide, leading to severe side effects like hypoglycemia and seizures. The European Medicines Agency (EMA) and Austria's Federal Office for Safety in Health Care (BASG) have issued warnings about these falsified products.To know more contact +4369919040849 or visit https://onlyhandsbyanna.com/
Like
Comment
Share
